CABA
USDCabaletta Bio Inc. Common Stock
即時價格
價格圖表
關鍵指標
市場指標
開盤
$2.860
最高
$2.970
最低
$2.630
交易量
3.67M
公司基本面
市值
247.0M
行業
生物科技
國家
United States
交易統計
平均交易量
3.63M
交易所
NMS
貨幣
USD
52週範圍
相關新聞
Cabaletta Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
Rese-cel data presented at multiple medical meetings demonstrated potentially transformative, drug-free clinical responses with a favorable safety profile for autoimmune patients supporting outpatient use All myositis
FDA's Rigid Approach Adds Uncertainty To uniQure's Accelerated Pathway For Huntington's Gene Therapy
William Blair notes FDA's tougher stance on gene therapy programs as AMT-130 faces uncertainty in its accelerated approval timeline.
Cantor Fitzgerald Maintains Overweight on Cabaletta Bio, Raises Price Target to $30
Cantor Fitzgerald analyst Josh Schimmer maintains Cabaletta Bio with a Overweight and raises the price target from $15 to $30.
Cabaletta Bio Presents Positive Clinical Data and Development Updates for Rese-cel at ACR Convergence 2025
– All myositis patients in the Phase 1/2 DM/ASyS cohort with sufficient follow-up who met key registrational inclusion criteria exceeded the registrational primary endpoint, demonstrating major TIS responses with no
相關股票
保持更新
設定價格提醒，獲取AI分析更新和即時市場新聞。